Given that high glucose levels reduce hENT1 expression and increase pancreatic cancer cell proliferation [17-20], we investigated the effect of fasting on gemcitabine efficacy in vitro and in an in vivo pancreatic cancer mouse xenograft model. This evidence concerns the gene SLC29A1 and pancreatic neoplasm.